Pharmacological approaches to discovery and development of new mucolytic agents

被引:61
作者
King, M [1 ]
Rubin, BK
机构
[1] Univ Alberta, Pulm Res Grp, Heritage Med Res Ctr 173, Edmonton, AB T6G 2S2, Canada
[2] Wake Forest Univ, Dept Pediat Biomed Engn Physiol & Pharmacol, Winston Salem, NC 27109 USA
关键词
airway mucus; mucociliary clearance; mucoactive agents; mucolytic agents; mucus secretion;
D O I
10.1016/S0169-409X(02)00156-4
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Airway mucus is the secretory product of the mucous cells; it is a variable mixture of water, mucous glycoproteins, low molecular weight ions, proteins, and lipids, whose physical properties are important for airway defense. The factors that contribute to the physical properties of mucus are complex, and there are a number of pharmacological strategies' that can potentially serve to improve the clearability of airway mucus. Novel mucoactive approaches include strategies for mucoregulation - decreasing the abnormal volume of mucus secretion - and medications designed to improve the cough clearability of airway secretions. In vitro results suggest potential benefits from the additive effects of selected combinations of mucoactive medications. Further studies are required to confirm these findings, to perform direct assessments of mucus clearability, and to extend the observations to patients with various types of pulmonary diseases where mucoactive treatments are required. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1475 / 1490
页数:16
相关论文
共 89 条
[1]
PREVENTING BRONCHOCONSTRICTION IN EXERCISE-INDUCED ASTHMA WITH INHALED HEPARIN [J].
AHMED, T ;
GARRIGO, J ;
DANTA, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (02) :90-95
[2]
[Anonymous], 1989, DRUGS BRONCIAL MUCOL
[3]
[Anonymous], 1978, RESP PHARM THERAPEUT
[4]
Anzueto A, 1997, JAMA-J AM MED ASSOC, V278, P1426
[5]
Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis [J].
App, EM ;
Baran, D ;
Dab, I ;
Malfroot, A ;
Coffiner, M ;
Vanderbist, F ;
King, M .
EUROPEAN RESPIRATORY JOURNAL, 2002, 19 (02) :294-302
[6]
APP EM, 1997, AM J RESP CRIT CARE, V155, pA199
[7]
Inhibition by dextran of Pseudomonas aeruginosa adherence to epithelial cells [J].
Barghouthi, S ;
Guerdoud, LM ;
Speert, DP .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (06) :1788-1793
[8]
Evidence that a peptide corresponding to the rat Muc2 C-terminus undergoes disulphide-mediated dimerization [J].
Bell, SL ;
Khatri, IA ;
Xu, GQ ;
Forstner, JF .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 253 (01) :123-131
[9]
MOVEMENT OF MUCUS IN LUNG [J].
BLAKE, J .
JOURNAL OF BIOMECHANICS, 1975, 8 (3-4) :179-190
[10]
HUMAN AIRWAY ION-TRANSPORT .1. [J].
BOUCHER, RC .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (01) :271-281